Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $387K 2,009 sh | Jul 7, 2026 |
| 31 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $1.37M 7,206 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Lechleider RobertChief Medical Officer |  IMNMImmunome Inc.Open-market sale · 10b5-1 plan | SELL | $377K 16.1K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Robins Harlan SChief Scientific Officer | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $3.30M 146.9K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 30 | Robins Harlan SChief Scientific Officer | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $5.20M 239.4K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 29 | Puylaert KevinChief Sales Officer |  SOPHSOPHiA GENETICS SAOpen-market sale | SELL | $158 31 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 29 | Sankar ShyamSee Remarks | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $19.50M 150.0K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 29 | Puylaert KevinChief Sales Officer | SOPHSOPHiA GENETICS SA Open-market sale | SELL | $236 47 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 29 | Puylaert KevinChief Sales Officer | SOPHSOPHiA GENETICS SA Open-market sale | SELL | $693 138 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 29 | Treseder Oluwadara JohnsonDirector | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $225K 1,875 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 29 | Treseder Oluwadara JohnsonDirector | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $216K 1,875 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 26 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $19K 100 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 26 | Lechleider RobertChief Medical Officer | IMNMImmunome Inc. Open-market sale · 10b5-1 plan | SELL | $499K 22.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 26 | Lechleider RobertChief Medical Officer | IMNMImmunome Inc. Open-market sale · 10b5-1 plan | SELL | $369K 16.2K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 25 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $506K 2,586 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 25 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $283K 1,436 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 25 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $475K 2,438 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 24 | Holme TimothyCHIEF TECHNOLOGY OFFICER |  QSQuantumScape CorpOpen-market sale · 10b5-1 plan | SELL | $249K 34.3K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 24 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $567K 2,986 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 23 | Barchas IsaacDirector | IMNMImmunome Inc. Open-market sale · 10b5-1 plan | SELL | $2.00M 83.1K sh | Jul 7, 2026 traded Jul 6, 2026 |
| 22 | Sankar ShyamSee Remarks | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $4.55M 35.0K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 22 | Mountcastle DavidEVP & Chief Financial Officer |  PRVAPrivia Health Group, Inc.Open-market sale · 10b5-1 plan | SELL | $680K 24.7K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 22 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $229K 1,160 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 22 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $129K 651 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 22 | Perry Jennifer ScottChief Operating Officer | BCYCBICYCLE THERAPEUTICS PLC Open-market sale · 10b5-1 plan | SELL | $4,424 1,036 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 22 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $242K 1,249 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 20 | Collier CharlesPresident, Roku Media | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $1.29M 9,043 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 20 | Collier CharlesPresident, Roku Media | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $1.29M 9,043 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $39K 200 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 19 | Holme TimothyCHIEF TECHNOLOGY OFFICER | QSQuantumScape Corp Open-market sale · 10b5-1 plan | SELL | $750K 103.0K sh | Jul 7, 2026 traded Jul 2, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $46K 240 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $7,979 40 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 19 | Fitzpatrick JenniferChief Legal Officer |  SIONSionna Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $447K 10.3K sh | Jul 7, 2026 traded Jul 6, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $362K 1,820 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 19 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $308K 1,540 sh | Jul 7, 2026 traded Jul 6, 2026 |
| 17 | Friedberg Ezra MDirector |  PTHSPelthos Therapeutics Inc.Open-market sale · 10b5-1 plan | SELL | $14K 534 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 17 | Pauls MatthewDirector | PTHSPelthos Therapeutics Inc. Open-market sale · 10b5-1 plan | SELL | $18K 692 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 17 | Pauls MatthewDirector | PTHSPelthos Therapeutics Inc. Open-market sale · 10b5-1 plan | SELL | $2,572 94 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 17 | Greenleaf PeterDirector | PTHSPelthos Therapeutics Inc. Open-market sale · 10b5-1 plan | SELL | $2,318 85 sh | Jul 7, 2026 traded Jul 2, 2026 |
| 17 | Xu Cong ClaireSVP, Clinical Development |  NBPNovaBridge BiosciencesOpen-market sale | SELL | $3,992 4,485 sh | Jul 7, 2026 traded Jul 6, 2026 |